Array BioPharma, Inc

Country
USA
Краткое название
Array BioPharma, Inc
Headquarters
3200 Walnut Street
Members of the board

Ron Squarer,
Chief Executive Officer
R. Michael Carruthers,
Chief Financial Officer
Gary M. Clark, Ph.D.,
Vice President, Biostatistics & Data Management
Howard Holden, Ph.D.,
Vice President, Regulatory Affairs & Quality Assurance
Kevin  Koch, Ph.D.,
President & Chief Scientific Officer
Patrice Lee, Ph.D.,
Vice President, Pharmacology & Toxicology
John R. Moore,
Vice President & General Counsel
Andrew Robbins,
Senior Vice President, Commercial Operations
David L. Snitman, Ph.D.,
Chief Operating Officer & Vice President, Business Development
James D. Winkler, Ph.D.,
Vice President, Discovery & Translational Biology
Karsten Witt, M.D.,
Vice President, Clinical Sciences

Categories medicine
Oncology, Infectious diseases
Stage of the project
Production
Disease
Viral hepatitis, Blood cancer, Breast cancer
Ticker
ARRY
Current owners

Gwen A. Fyfe, M.D.,
Independent Consultant & Former Vice President, Oncology Development, Genentech, Inc.
Kyle A. Lefkoff - Chairman
General Partner, Boulder Ventures, LTD
John A. Orwin,
Chief Executive Officer, Affymax, Inc.
Liam Ratcliffe, M.D., Ph.D.,
General Partner, New Leaf Venture Partners
Ron Squarer,
Chief Executive Officer
Gil J. Van Lunsen
Former Managing P,artner, KPMG
John L. Zabriskie, Ph.D.,
Co-Founder & Director of Puretech Ventures, LLC & Former President & Chief Executive Officer, Pharmacia and Upjohn Inc.

Assets
1.0800
Technology
Other, Cell Technologies, Devices, Services, Technologies, Pharmaceuticals, Chemistry